Quentis Therapeutics

Developer of therapies for treating cancer and neurodegenerative diseases

placeNew York City, New York, United States calendar_todayFounded 2016 groups4 employees language quentistx.com

Registered entities

Innovation

5 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 105 times.

YearFilings
20184
20193
20203
20211

Investor mix

8 investors on record; lead investors include Versant Ventures, Polaris Partners.

Investor typeCountShare
Venture capital450%
Private equity113%
Other / undisclosed338%
Coming soon